We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WTFCN:NASDAQWintrust Financial Corporation - Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 7.875% Fixed-Rate Reset Non-Cumulative Perpetual Prefer Analysis

Data as of 2026-07-22 - not real-time

$26.11

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Wintrust Financial is trading just above its near‑term support of $25.85, with the price at $26.11 sitting slightly under the 20‑day (26.14) and 50‑day (26.24) SMAs, signaling a modest bearish bias. The RSI of 47.4 suggests momentum is neutral, while the MACD line has crossed above its signal, offering a faint bullish cue. Volume has been trending down, and the stock’s beta of 0.13 points to very low market‑related volatility, reinforced by a 30‑day volatility of just over 5% and a modest max drawdown of 6%. Fundamentally, the company posted a record six‑month net income of $461.1 million (≈$6.52 EPS), delivering a 10% revenue growth year‑over‑year and robust operating (46%) and profit (33%) margins. Its dividend yield of 8.67% (2.26 per share) is exceptionally high, yet the implied payout ratio—based on the reported earnings—is well below 50%, indicating sustainability. The price‑to‑book ratio of 0.26 versus a book value of $102 per share underscores a deep valuation discount, while cash on hand exceeds debt, providing a solid balance‑sheet cushion. Recent news of a record net income and the acquisition of Northern Trust’s guardianship services further bolsters the growth narrative, positioning Wintrust as a potentially attractive dividend‑play with upside if the price can break above the $26.48 resistance level.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support with bearish SMA alignment
  • Bullish MACD crossover offering short‑term upside
  • High dividend yield providing income cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong earnings growth and record net income
  • Deep valuation discount (P/B ~0.26)
  • Sustainable high dividend supporting total return

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Low beta and volatility indicating defensive profile
  • Robust balance sheet with cash exceeding debt
  • Strategic expansion via acquisition of guardianship services

Key Metrics & Analysis

Financial Health

Revenue Growth10.40%
Profit Margin32.63%
ROE12.21%
ROA1.25%
P/B Ratio0.3
Industry P/E17.7

Technical Analysis

TrendBearish
RSI47.4
Support$25.85
Resistance$26.48
MA 20$26.14
MA 50$26.24
MA 200$26.30
MACDBullish
VolumeDecreasing
Fear & Greed Index91.16

Valuation

GradeUndervalued
TypeBlend
Dividend Yield8.67%

Risk Assessment

Beta0.13
Volatility5.26%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.